103 related articles for article (PubMed ID: 8816581)
1. Immunophenotypic analysis of CD5 positivity in paraffin-embedded tissues. Still waiting for an effective diagnostic antibody.
Perkins SL
Am J Clin Pathol; 1996 Sep; 106(3):273-4. PubMed ID: 8816581
[No Abstract] [Full Text] [Related]
2. CD5- small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia.
Huang JC; Finn WG; Goolsby CL; Variakojis D; Peterson LC
Am J Clin Pathol; 1999 Jan; 111(1):123-30. PubMed ID: 9894463
[TBL] [Abstract][Full Text] [Related]
3. CD5 immunostaining of lymphoid neoplasms in paraffin sections.
Butmarc J; Kourea HP; Kadin ME
Am J Clin Pathol; 1997 Apr; 107(4):496-7; author reply 497. PubMed ID: 9124221
[No Abstract] [Full Text] [Related]
4. CD5 immunostaining of lymphoid neoplasms in paraffin sections.
Salhany KE; van de Rijn M; Montone KT; Tomaszewski JE
Am J Clin Pathol; 1997 Apr; 107(4):496; author reply 497. PubMed ID: 9124220
[No Abstract] [Full Text] [Related]
5. Improved detection of CD5 epitope in formalin-fixed paraffin-embedded sections of benign and neoplastic lymphoid tissues by using biotinylated tyramine enhancement after antigen retrieval.
Butmarc JR; Kourea HP; Levi E; Kadin ME
Am J Clin Pathol; 1998 Jun; 109(6):682-8. PubMed ID: 9620024
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of CD5 with monoclonal antibody 4C7 on paraffin sections.
Kaufmann O; Flath B; Späth-Schwalbe E; Possinger K; Dietel M
Am J Clin Pathol; 1997 Dec; 108(6):669-73. PubMed ID: 9384449
[TBL] [Abstract][Full Text] [Related]
7. CD5 labeling of thymic carcinomas and other nonlymphoid neoplasms.
Kornstein MJ; Rosai J
Am J Clin Pathol; 1998 Jun; 109(6):722-6. PubMed ID: 9620029
[TBL] [Abstract][Full Text] [Related]
8. CD5 immunoreactivity of epithelial cells in thymic carcinoma and CASTLE using paraffin-embedded tissue.
Berezowski K; Grimes MM; Gal A; Kornstein MJ
Am J Clin Pathol; 1996 Oct; 106(4):483-6. PubMed ID: 8853036
[TBL] [Abstract][Full Text] [Related]
9. Antibody NCL-CD5 fails to detect neoplastic CD5+ cells in paraffin sections.
Ben-Ezra JM; Kornstein MJ
Am J Clin Pathol; 1996 Sep; 106(3):370-3. PubMed ID: 8816596
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in paraffin sections.
Dorfman DM; Shahsafaei A
Mod Pathol; 1997 Sep; 10(9):859-63. PubMed ID: 9310947
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of mycosis fungoides on paraffin-embedded tissue sections.
Izban KF; Hsi ED; Alkan S
Mod Pathol; 1998 Oct; 11(10):978-82. PubMed ID: 9796726
[TBL] [Abstract][Full Text] [Related]
12. [The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].
Yi S; Li Z; Wang H; Liu W; Lyu R; Yu Z; Qi J; Qiu L
Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):337-41. PubMed ID: 24759024
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness of the immunologic phenotype in the diagnosis of chronic lymphoproliferative syndromes with splenomegaly as the dominant clinical manifestation].
Silva Rodrigues A; Orfao A; Macedo A; González M; San Miguel J; López-Berges MC; Graça F; Mesonero J; López Borrasca A
Sangre (Barc); 1990 Oct; 35(5):369-73. PubMed ID: 2291146
[TBL] [Abstract][Full Text] [Related]
14. CD5-expressing B-cell lymphomas/leukemias: relatively high frequency of CD5+ B-cell lymphomas with an overall poor prognosis in Nagasaki Japan.
Kamihira S; Hirakata Y; Atogami S; Sohda H; Tsuruda K; Yamada Y; Tomonaga M
Leuk Lymphoma; 1996 Jun; 22(1-2):137-42. PubMed ID: 8724541
[TBL] [Abstract][Full Text] [Related]
15. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
16. Detection of CD5 antigen on B cell lymphomas in fixed, paraffin embedded tissues using signal amplification by catalyzed reporter deposition.
Luo JH; Matsushima AY; Chen R; Szabolcs MJ
Eur J Histochem; 1998; 42(1):31-9. PubMed ID: 9615189
[TBL] [Abstract][Full Text] [Related]
17. CD5+ persistent polyclonal B-cell lymphocytosis in a male.
Reeder CB; Conley CR
Leuk Lymphoma; 1999 May; 33(5-6):593-6. PubMed ID: 10342588
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphoproliferative disorders: an integrated point of view for the differential diagnosis.
D'Arena G; Keating MJ; Carotenuto M
Leuk Lymphoma; 2000 Jan; 36(3-4):225-37. PubMed ID: 10674895
[TBL] [Abstract][Full Text] [Related]
19. Chronic B-cell lymphoproliferative disease: relationship between immunophenotype and clinical stage.
Dazzi F; Veronesi A; D'Andrea E; Sgarabotto D; Girolami A
Haematologica; 1990; 75(3):243-8. PubMed ID: 2227621
[TBL] [Abstract][Full Text] [Related]
20. CD5+ B-cell lymphoproliferative disorders: Beyond chronic lymphocytic leukemia and mantle cell lymphoma.
Jevremovic D; Dronca RS; Morice WG; McPhail ED; Kurtin PJ; Zent CS; Hanson CA
Leuk Res; 2010 Sep; 34(9):1235-8. PubMed ID: 20362334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
